Design Therapeutics Inc
NASDAQ:DSGN
Design Therapeutics Inc
NASDAQ:DSGN
Price:
4.77 USD
1.71%
Updated:
May 10, 2024
Balance Sheet
Balance Sheet Decomposition
Design Therapeutics Inc
Design Therapeutics Inc
| Current Assets | 284.6m |
| Cash & Short-Term Investments | 281.8m |
| Receivables | 1.4m |
| Other Current Assets | 1.4m |
| Non-Current Assets | 5.1m |
| PP&E | 4.6m |
| Other Non-Current Assets | 430k |
| Current Liabilities | 9.6m |
| Accounts Payable | 1.9m |
| Accrued Liabilities | 7.7m |
| Non-Current Liabilities | 2.3m |
| Other Non-Current Liabilities | 2.3m |
Balance Sheet
Design Therapeutics Inc
Design Therapeutics Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
2
|
299
|
27
|
21
|
|
| Cash Equivalents |
0
|
2
|
299
|
27
|
21
|
|
| Short-Term Investments |
0
|
34
|
86
|
304
|
261
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
0
|
0
|
1
|
5
|
1
|
|
| Total Current Assets |
0
|
36
|
385
|
335
|
285
|
|
| PP&E Net |
0
|
0
|
5
|
6
|
5
|
|
| PP&E Gross |
0
|
0
|
5
|
6
|
5
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
0
|
|
| Total Assets |
0
N/A
|
37
+36 400%
|
391
+970%
|
341
-13%
|
290
-15%
|
|
| Liabilities | ||||||
| Accounts Payable |
3
|
1
|
2
|
3
|
2
|
|
| Accrued Liabilities |
0
|
1
|
4
|
8
|
8
|
|
| Short-Term Debt |
1
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
2
|
5
|
11
|
10
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
3
|
3
|
2
|
|
| Total Liabilities |
4
N/A
|
3
-32%
|
8
+236%
|
14
+64%
|
12
-13%
|
|
| Equity | ||||||
| Common Stock |
0
|
45
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
12
|
48
|
111
|
178
|
|
| Additional Paid In Capital |
0
|
1
|
430
|
441
|
455
|
|
| Other Equity |
0
|
0
|
0
|
3
|
0
|
|
| Total Equity |
4
N/A
|
34
N/A
|
382
+1 024%
|
327
-14%
|
278
-15%
|
|
| Total Liabilities & Equity |
0
N/A
|
37
+36 400%
|
391
+970%
|
341
-13%
|
290
-15%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
54
|
54
|
55
|
56
|
56
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
